Lonza Group (OTCMKTS:LZAGY) Stock Passes Below Fifty Day Moving Average Following Analyst Downgrade

Lonza Group Ag (OTCMKTS:LZAGY)’s share price passed below its fifty day moving average during trading on Thursday after Zacks Research downgraded the stock from a hold rating to a strong sell rating. The stock has a fifty day moving average of $68.23 and traded as low as $66.02. Lonza Group shares last traded at $66.36, with a volume of 50,903 shares trading hands.

Lonza Group Trading Up 0.8%

The stock has a 50 day moving average of $68.20 and a 200 day moving average of $68.65. The company has a quick ratio of 0.87, a current ratio of 1.46 and a debt-to-equity ratio of 0.48.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.